Fanconi Anemia
AI:n luoma kuva
Stanford antibody regimen enables stem cell transplants without radiation or busulfan in Fanconi anemia
Raportoinut AI AI:n luoma kuva Faktatarkistettu
A Stanford Medicine team reports that a single dose of the anti‑CD117 antibody briquilimab allowed three children with Fanconi anemia to undergo stem cell transplants without radiation or busulfan, achieving near‑complete donor cell engraftment in a phase 1b study published in Nature Medicine.